missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies SU9516
Beskrivelse
- SU9516 is a specific inhibitor of cyclin-dependent kinases (CDKs) including CDK2, CDK1 and, to a lesser extent, CDK4 with IC50 values of 22, 40, and 200 nM, respectively (Lane et al.) It competitively binds in the ATP binding pocket of CDK2 and CDK1 (Moshinsky et al.) It is highly selective and does not inhibit PKC, p38 MAPK, PDGFR or EGFR (IC50 > 10 μM; Lane et al.)
- Decreases proliferation in human colon carcinoma cell lines RKO and SW480, through inhibition of retinoblastoma protein (Rb) phosphorylation, resulting in increased Rb/E2F, cell-cycle arrest, and subsequent apoptosis (Lane et al.; Yu et al.)
- Induces mitochondrial injury, caspase activation and subsequent apoptosis through downregulated transcription of the antiapoptotic protein MCL-1 in U937, Jurkat, and HL-60 leukemia or lymphoma cell lines (Gao et al.)
- Induces apoptosis, alone or in combination with paclitaxel, in the inflammatory breast cancer cell line SUM149PT (Opyrchal et al.)
Tekniske data
Tekniske data
| CAS | 377090-84-1 |
| Cantidad | 10 mg |
| Fórmula molecular | C13H11N3O2 |
| Pureza | ≥98% |
Produkttitel
Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.
Ser du en mulighed for forbedring?